Botulinum Toxin-A For Management of Migraine: An Experience in Iraq
College of Dentistry, University of Tikrit, Tikrit, Iraq
College of Dentistry, University of Tikrit, Tikrit, Iraq.
College of Dentistry, University of Tikrit, Tikrit, Iraq.
College of Dentistry, University of Tikrit, Tikrit, Iraq.
Abstract
Background
Iraq as a country, doesn’t have any facts or details about using botulinum toxin for the prevention of migraine. The main goal of this experience, is to study the clinical profile and response to treatment with botulinum toxin injection for migraine patients. Migraine is a headache illness identified by repeated attacks of moderate to severe pain, nausea, photophobia, and phonophobia. Botulinumtoxin A is used to prevent and treat migraine.
Aim of the study
To estimate the effectiveness of botulinum toxin-A injections for managing migraine and prove the usefulness and safety of botulinum toxin -A.
Materials and methods
The study sample included 23 patients aged 20-45, 8 males and 15 females, diagnosed with migraines for more than one year. Patients with neurological or cardiovascular disorders and pregnant women were not included from the study. Botox powder 150 units and a 30-gauge needle were used to inject 30 injections, with 5 units of botulinum toxin in each injection site.
Results
Ranging from non-responders (4.4%) to partial responders (4.4%), responders (26%) and high responders (65.4%). The constancy of migraine days revealed a clear reduction from the original percentage after three months of botulinum toxin injection.
Conclusion
Botulinum toxin A is a useful alternative for chronic migraine patients who do not benefit from other medications. In chronic migraine botulinum toxin, A is helpful in terms of quality of life, headache frequency, and pain intensity. Botulinum toxin A therapy is safe and tolerated.
Partners
